The launch of clinical trials to link the brain of patients with nervous and computer in Abu Dhabi

“Neuralink” announced the launch of its clinical trial for the first time in the Middle East at Cleveland Clinic Abu Dhabi in partnership with the Health Department-Abu Dhabi, and the UAE-PRIME experience explores how individuals who suffer from poor movement and pronunciation can use thought to control devices and communication.

For his part, the head of the Health Department-Abu Dhabi, Mansour Ibrahim Al-Mansouri, confirmed that the launch of the UAE-PRIME clinical experience with “Neuralink” in Abu Dhabi, to be the first global headquarters outside the North American continent of this clinical experience, represents a milestone in the future of health.

Al -Mansouri said: “In cooperation with the Cleveland Clinic Abu Dhabi Hospital, we are proud to enable the safe and responsible development of the technology of linking the brain and computer, giving hope to many who suffer from severe neurological diseases,” noting that this partnership reflects Abu Dhabi’s commitment to promoting innovation in health and life sciences by pushing the wheel of developing promising revolutionary technologies that are subject to testing to ensure their safety and effectiveness, Likewise, her judgment and provision for patients who need it around the world. ”

For his part, the CEO of the Cleveland Clinic Abu Dhabi Hospital, Dr. George Pascal Heber, indicated that the UAE’s Prime experience from Neuralink represents a pivotal step in the development of nervous cases. As the first hospital outside North America to participate in this initiative, Cleveland Clinic Abu Dhabi is proud to provide the technology of linking the brain and computer, which will change the lives of patients in the UAE and abroad, as this achievement represents a milestone that embodies our commitment to advance the wheel of progress in medical sciences, and our keenness to make a real impact on patients ’life through innovation.